Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Companies
Recent news which mentions Companies
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
30
31
Next >
Illumina shareholders vote to install Carl Icahn board nominee, oust chair
May 25, 2023
Tags
Business News
Markets
Biotech and Pharmaceuticals
From
CNBC.com News
FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults
May 25, 2023
Tags
Biotech and Pharmaceuticals
Health care industry
Diagnosis and treatment
From
CNBC.com News
Here’s what Pfizer and Moderna say is next for their Covid vaccines
May 22, 2023
Tags
Pfizer Inc
Pharmaceuticals
Science
From
CNBC.com News
Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
May 22, 2023
Tags
Biotech and Pharmaceuticals
Diabetes
Drug trials
From
CNBC.com News
VistaJet CEO defends company's financials as auditor raises liquidity, debt concerns
May 19, 2023
Tags
Airlines
Aerospace and defense industry
Aerospace & Defense
From
CNBC.com News
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
May 18, 2023
Tags
Business
US: News
Science
From
CNBC.com News
Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
May 18, 2023
Tickers
LAW
LAWS
Tags
Health care industry
Horizon Therapeutics PLC
Biotech and Pharmaceuticals
From
CNBC.com News
NJ Gov. Murphy would consider defying Supreme Court if justices back abortion pill ban
May 17, 2023
Tags
Business News
Breaking News: Politics
Social issues
From
CNBC.com News
Pfizer to raise $31 billion in debt offering to fund Seagen acquisition, SEC filing shows
May 17, 2023
Tags
Business News
Health care industry
Corporate Debt
From
CNBC.com News
Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say
May 16, 2023
Tags
GSK plc
Vaccinations
Biotechnology
From
CNBC.com News
Google Cloud launches A.I.-powered tools to accelerate drug discovery, precision medicine
May 16, 2023
Tags
Business News
Genetics research
Biotech and Pharmaceuticals
From
CNBC.com News
Horizon Therapeutics stock plunges on report FTC is preparing to block Amgen deal
May 16, 2023
Tags
Business
US: News
Health & Science
From
CNBC.com News
Amazon is focusing on using A.I. to get stuff delivered to you faster
May 15, 2023
Tags
Logistical and moving services
Technology: Companies
Internet
From
CNBC.com News
Americans in most states will no longer receive Covid exposure notifications on phones
May 12, 2023
Tags
Biotechnology
Technology
Companies
From
CNBC.com News
Netflix's $2.5 billion investment in Korean content appeals to audiences worldwide
May 12, 2023
Tags
Netflix Inc
Television programs
Media
From
CNBC.com News
Pfizer CEO says Medicare will likely face legal action over drug price negotiations
May 11, 2023
Tags
US: News
Business
Pharmaceuticals
From
CNBC.com News
GOP law cut Big Pharma tax rates by 40%, Senate report says
May 11, 2023
Tickers
LAW
LAWS
Tags
Pharmaceuticals
Health & Science
US: News
From
CNBC.com News
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
May 10, 2023
Tags
Business News
Breaking News: Politics
Congress
From
CNBC.com News
Novavax shares rise after company unveils positive vaccine data, plan to cut 25% of workforce
May 09, 2023
Tags
Biotech and Pharmaceuticals
Moderna Inc
Health care industry
From
CNBC.com News
Oil giant Saudi Aramco posts 19% drop in first-quarter profit
May 09, 2023
Tickers
OIL
Tags
Emerging markets
Oil
Energy
From
CNBC.com News
Tech's been hit by layoffs. But Singapore is still investing big in its talent — in tech and beyond
May 08, 2023
Tickers
JOBS
Tags
Personnel
Technology
Companies
From
CNBC.com News
Kenvue CEO looks to brand, product innovation to drive growth after IPO
May 05, 2023
Tickers
IPO
IPOS
Tags
Business News
Johnson & Johnson
IPOs
From
CNBC.com News
J&J's consumer health spinoff Kenvue opens at $25.53, a 16% jump, in public market debut
May 04, 2023
Tickers
IPO
IPOS
Tags
Biotech and Pharmaceuticals
Breaking News: Markets
Health care industry
From
CNBC.com News
Moderna posts surprise quarterly profit despite waning demand for Covid vaccines
May 04, 2023
Tags
Moderna Inc
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
May 03, 2023
Tags
Pfizer Inc
Pharmaceuticals
Health & Science
From
CNBC.com News
J&J's consumer health business Kenvue is going public this week. Here's what to know
May 03, 2023
Tickers
IPO
IPOS
Tags
Health & Science
IPO
Pharmaceuticals
From
CNBC.com News
Pfizer earnings and revenue top expectations despite sales declines
May 02, 2023
Tags
Coronavirus
Earnings
Breaking News: Business
From
CNBC.com News
Carl Icahn calls Illumina Q1 results ‘very disappointing,’ slams cost-cutting plan
April 28, 2023
Tickers
LAW
LAWS
Tags
Laws
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Merck revenue falls after dramatic drop in sales of Covid antiviral treatment
April 27, 2023
Tags
Johnson & Johnson
Business News
Merck & Co Inc
From
CNBC.com News
Illumina CEO touts Grail’s 100% revenue growth amid proxy fight with Icahn
April 26, 2023
Tags
Mergers
Business News
Markets
From
CNBC.com News
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.